Picture of Ascletis Pharma logo

1672 — Ascletis Pharma Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Momentum

Relative Strength (%)
1m+16.17%
3m-17.47%
6m+15.14%
1yr+49.18%
Volume Change (%)
10d/3m-64.05%
Price vs... (%)
52w High-46.01%
50d MA+0.14%
200d MA+4.62%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-6.61%
Return on Equity-6.97%
Operating Margin-235.47%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Ascletis Pharma EPS forecast chart

Profile Summary

Ascletis Pharma Inc. is a China-based company principally engaged in the research and development of biological products. The Company is focused on three therapeutic areas, including anti-viral, cancer and fatty liver disease. The Company’s main products include drugs against hepatitis C virus (HCV), human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
February 25th, 2014
Public Since
August 1st, 2018
No. of Employees
266
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
hk flag iconStock Exchange of Hong Kong Limited
Shares in Issue
1,087,134,000
Blurred out image of a map
Address
HANGZHOU
Web
http://www.ascletis.com/
Phone
Auditors
Ernst & Young CPA

1672 Share Price Performance

Upcoming Events for 1672

Similar to 1672

Picture of 3SBio logo

3SBio

hk flag iconStock Exchange of Hong Kong Limited

Picture of Asymchem Laboratories Tianjin Co logo

Asymchem Laboratories Tianjin Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of Guangzhou Baiyunshan Pharmaceutical Holdings Co logo

Guangzhou Baiyunshan Pharmaceutical Holdings Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of Canbridge Pharmaceuticals logo

Canbridge Pharmaceuticals

hk flag iconStock Exchange of Hong Kong Limited

Picture of Cansino Biologics logo

Cansino Biologics

hk flag iconStock Exchange of Hong Kong Limited

FAQ

Or unlock with your email

Or unlock with your email